JPWO2022138909A1 - - Google Patents
Info
- Publication number
- JPWO2022138909A1 JPWO2022138909A1 JP2022571676A JP2022571676A JPWO2022138909A1 JP WO2022138909 A1 JPWO2022138909 A1 JP WO2022138909A1 JP 2022571676 A JP2022571676 A JP 2022571676A JP 2022571676 A JP2022571676 A JP 2022571676A JP WO2022138909 A1 JPWO2022138909 A1 JP WO2022138909A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Botany (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023166660A JP7432053B2 (ja) | 2020-12-24 | 2023-09-28 | シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物 |
JP2024014953A JP7484030B2 (ja) | 2020-12-24 | 2024-02-02 | シクロデキストリンにエクオールが包接された包接体の製造方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020215247 | 2020-12-24 | ||
JP2020215247 | 2020-12-24 | ||
PCT/JP2021/048167 WO2022138909A1 (ja) | 2020-12-24 | 2021-12-24 | シクロデキストリンにエクオールが包接された包接体、該包接体を含有するエクオール吸収性組成物、及びこれらの製造方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023166660A Division JP7432053B2 (ja) | 2020-12-24 | 2023-09-28 | シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JPWO2022138909A1 true JPWO2022138909A1 (ja) | 2022-06-30 |
JPWO2022138909A5 JPWO2022138909A5 (ja) | 2023-08-18 |
JP7359973B2 JP7359973B2 (ja) | 2023-10-11 |
Family
ID=82158029
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022571676A Active JP7359973B2 (ja) | 2020-12-24 | 2021-12-24 | エクオールの経口による血中吸収性を向上させる方法及びβ-シクロデキストリンからなるエクオールの血中吸収促進剤 |
JP2023166660A Active JP7432053B2 (ja) | 2020-12-24 | 2023-09-28 | シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物 |
JP2024014953A Active JP7484030B2 (ja) | 2020-12-24 | 2024-02-02 | シクロデキストリンにエクオールが包接された包接体の製造方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023166660A Active JP7432053B2 (ja) | 2020-12-24 | 2023-09-28 | シクロデキストリンにエクオールが包接された包接体を含有するエクオール吸収性組成物 |
JP2024014953A Active JP7484030B2 (ja) | 2020-12-24 | 2024-02-02 | シクロデキストリンにエクオールが包接された包接体の製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20240082424A1 (ja) |
JP (3) | JP7359973B2 (ja) |
WO (1) | WO2022138909A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012135218A (ja) * | 2010-12-24 | 2012-07-19 | Daicel Corp | エクオールの製造法、エクオール産生組成物、食品、食品添加物及び医薬品 |
WO2013058303A1 (ja) * | 2011-10-18 | 2013-04-25 | ラクオリア創薬株式会社 | 医薬組成物 |
JP2020058319A (ja) * | 2018-10-12 | 2020-04-16 | 株式会社ダイセル | 6−ヒドロキシダイゼインの製造方法 |
JP2020092690A (ja) * | 2018-12-07 | 2020-06-18 | 学校法人東京理科大学 | エクオール誘導体の産生のための組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006111534A (ja) | 2004-10-12 | 2006-04-27 | Bio Taxol:Kk | クルクミン水溶液の製造方法 |
CN102726683B (zh) | 2005-12-06 | 2015-04-01 | 大塚制药株式会社 | 含雌马酚的大豆胚轴发酵物 |
CN102919739B (zh) | 2007-06-13 | 2014-07-02 | 大塚制药株式会社 | 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品 |
WO2020090137A1 (ja) | 2018-10-30 | 2020-05-07 | 太陽化学株式会社 | 容器詰飲料 |
JP7451185B2 (ja) | 2019-01-22 | 2024-03-18 | 株式会社ダイセル | 新規微生物およびその利用 |
-
2021
- 2021-12-24 JP JP2022571676A patent/JP7359973B2/ja active Active
- 2021-12-24 WO PCT/JP2021/048167 patent/WO2022138909A1/ja active Application Filing
- 2021-12-24 US US18/269,390 patent/US20240082424A1/en active Pending
-
2023
- 2023-09-28 JP JP2023166660A patent/JP7432053B2/ja active Active
-
2024
- 2024-02-02 JP JP2024014953A patent/JP7484030B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012135218A (ja) * | 2010-12-24 | 2012-07-19 | Daicel Corp | エクオールの製造法、エクオール産生組成物、食品、食品添加物及び医薬品 |
WO2013058303A1 (ja) * | 2011-10-18 | 2013-04-25 | ラクオリア創薬株式会社 | 医薬組成物 |
JP2020058319A (ja) * | 2018-10-12 | 2020-04-16 | 株式会社ダイセル | 6−ヒドロキシダイゼインの製造方法 |
JP2020092690A (ja) * | 2018-12-07 | 2020-06-18 | 学校法人東京理科大学 | エクオール誘導体の産生のための組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP7359973B2 (ja) | 2023-10-11 |
JP7484030B2 (ja) | 2024-05-15 |
JP2023165927A (ja) | 2023-11-17 |
US20240082424A1 (en) | 2024-03-14 |
JP7432053B2 (ja) | 2024-02-15 |
WO2022138909A1 (ja) | 2022-06-30 |
JP2024036485A (ja) | 2024-03-15 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230620 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230620 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230620 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230810 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230829 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230928 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7359973 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |